EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees.
about
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisStrategies for disseminating recommendations or guidelines to patients: a systematic review.The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationIs salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic reviewCanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summaryProper management of rheumatoid arthritis in Latin America. What the guidelines say?EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateNeuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological featuresEULAR recommendations for patient education for people with inflammatory arthritisDeveloping a checklist for guideline implementation planning: review and synthesis of guideline development and implementation adviceJuvenile Idiopathic Arthritis in the Era of International Cooperation.EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsEuropean League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studiesTreating rheumatoid arthritis to target: recommendations of an international task force.Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards.2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendationsTreating rheumatoid arthritis to target: the patient version of the international recommendations.Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology.ASAS/EULAR recommendations for the management of ankylosing spondylitis.EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice.Validation of potential classification criteria for systemic sclerosis.Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale.Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.Time to share.EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion?Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists.Guidelines for guideline developers: a systematic review of grading systems for medical testsTreating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis.Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise.Consensus-based recommendations for the management of juvenile dermatomyositis.Update on the use of biologics in primary systemic vasculitides.Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis.Early psoriatic arthritis: facing the challenge.Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever.
P2860
Q24603648-814C3B2C-C349-40C9-9E4E-94CA046CD2A8Q26748587-FF5A4320-5145-4CC1-9971-B38EF9694A45Q26765038-FCE7EFE5-DC2D-43EF-AECC-D4A5B29776DCQ26775918-917391CE-A216-4A64-81EA-B25414BF560FQ26777918-B503A28F-7106-469A-B5AC-182DD2440408Q26801231-2F805F47-F684-4FBA-9F71-4577DDAE00A8Q26859134-0170573D-D871-4BA5-B14E-1BAA6F7EAF08Q27000669-208138F7-5F3B-4A34-8E73-FF6564D6740FQ27010077-B7E19F22-6484-45AC-A479-785729138BEAQ28084774-E2079E58-0D65-4935-96D7-9D46D3F35AFEQ30235998-CE3299F5-58DC-4D4D-ACE2-309B5C290D5AQ33292103-8ADD0557-FAF4-495F-BAED-21026923CDDBQ34110066-7C8D359B-77B7-4AEA-AD29-153AF1C91CADQ34187282-B9606FE7-0AA1-4F0D-AED6-7FE758231CE5Q34462557-7BBD2873-7642-46E9-8B34-DDEC32A4C97FQ34727670-CA275291-1D1E-4154-B1F0-9DA225BB5078Q34818729-3D996B94-BDB4-4CD7-B8F2-056564A4FA5FQ34905363-37E0AF73-3DDF-4C1C-AD40-C1354CA71632Q35605474-94FC953A-23C7-4CEC-9CC2-52DB6FDF4EDBQ35637012-C106A824-AC0A-4C49-8033-BD04E9A11A46Q35638360-18CCA937-3B48-483E-9491-9121A2EFD7C9Q35642120-484F01A6-AE90-4054-B4AD-1EABDA8F8649Q36037437-ABB51ED1-87AC-469B-AEDA-DD05B5635196Q36171844-0A60DD43-4FC7-4186-895A-3089703A2F00Q36302245-A5E87DCF-0109-47FA-ABD0-D8637F33DD30Q36346681-6BD55D51-F672-42C0-9F1E-AAA9294C0290Q36643032-F4C72CA3-120A-4A38-B8D6-37F1AC47FD4BQ36684589-8A029384-9E65-4D76-8713-C47018104EE8Q36766114-599ABD67-5AA1-4A86-BB58-897973995CD3Q36932298-DE825887-8358-4EB9-A62F-D230E86C6E49Q37028486-286457CD-6B08-43D2-BB70-394C24666DDCQ37465349-E7AD4D2D-9263-423D-B4C4-81BEEA61ACE8Q37465518-3D618028-CE08-40DC-B993-1D32BFC969BBQ37591576-64595846-F2D9-4CA5-9A98-63F48F1E54BFQ37617000-59C43651-96C9-4CB8-B216-E3BA2CE1F5A3Q37754811-89FBD5C0-3ABF-456C-B469-5AB206E4861FQ37879814-E2CD249B-AF0A-4828-ADB3-612B076435EAQ38099750-6D778E10-E300-43B5-810E-AB9C8F413B17Q38143345-056F3907-EEF0-436D-9395-64EA40968094Q38335115-A3DE20A7-D331-49EA-86B7-A51893D3206C
P2860
EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
EULAR standardised operating p ...... the EULAR standing committees.
@en
EULAR standardised operating p ...... the EULAR standing committees.
@en-gb
type
label
EULAR standardised operating p ...... the EULAR standing committees.
@en
EULAR standardised operating p ...... the EULAR standing committees.
@en-gb
prefLabel
EULAR standardised operating p ...... the EULAR standing committees.
@en
EULAR standardised operating p ...... the EULAR standing committees.
@en-gb
P2093
P50
P356
P1476
EULAR standardised operating p ...... the EULAR standing committees.
@en
P2093
F Guillemin
J A P Da Silva
J Hirvonen
J R Kalden
L Euller-Ziegler
M Dougados
N Betteridge
P304
P356
10.1136/ARD.2004.023697
P407
P577
2004-09-01T00:00:00Z